Toxicity of β-amyloid vaccination in patients with Alzheimer's disease [1]

Annals of Neurology

Volumn 51, Issue 6, 2002, Pages 794-

  Imbimbo, Bruno Pietro ^a  

^a CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AIP 001; ALZHEIMER DISEASE VACCINE; QS 21;

ALZHEIMER DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CLINICAL TRIAL; ENCEPHALITIS; HUMAN; LETTER; MICROBIAL CONTAMINATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0036260808     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10218     Document Type: Letter

References (5)

1. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
2. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier
3. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
4. Immunization with beta-amyloid: Could T-cell activation have a harmful effect?
5. Transfected human B cells: A new model to study the functional and immunostimulatory consequences of APP production